Institutional investors purchased a net $71.2 thousand shares of SCLN during the quarter ended June 2014, and now own 57.16% of the total float, a percentage that is typical for companies in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FRANKLIN ADVISERS, INC. Bought 1.0 Million shares of SciClone Pharmaceuticals ...